- Previous Close
264.58 - Open
263.36 - Bid 265.01 x 900
- Ask 265.82 x 1100
- Day's Range
262.34 - 267.00 - 52 Week Range
213.31 - 406.46 - Volume
240,510 - Avg. Volume
1,589,591 - Market Cap (intraday)
31.926B - Beta (5Y Monthly) 0.58
- PE Ratio (TTM)
26.53 - EPS (TTM)
9.97 - Earnings Date Apr 30, 2025
- Forward Dividend & Yield 3.54 (1.34%)
- Ex-Dividend Date Mar 28, 2025
- 1y Target Est
296.92
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. It offers medical care and supplemental benefit plans to individuals. The company also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, it provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; and military services, such as TRICARE T2017 East Region contract. Further, the company engages in the operation of pharmacy benefit manager business; operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. It sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
www.humana.comRecent News: HUM
View MorePerformance Overview: HUM
Trailing total returns as of 3/31/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HUM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HUM
View MoreValuation Measures
Market Cap
31.93B
Enterprise Value
41.43B
Trailing P/E
26.51
Forward P/E
16.16
PEG Ratio (5yr expected)
1.58
Price/Sales (ttm)
0.27
Price/Book (mrq)
1.95
Enterprise Value/Revenue
0.35
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
1.02%
Return on Assets (ttm)
4.07%
Return on Equity (ttm)
7.41%
Revenue (ttm)
117.76B
Net Income Avi to Common (ttm)
1.21B
Diluted EPS (ttm)
9.97
Balance Sheet and Cash Flow
Total Cash (mrq)
20.43B
Total Debt/Equity (mrq)
76.90%
Levered Free Cash Flow (ttm)
-1.31B